Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Experience with Fingolimod in Clinical Practice.
The role of information system in multiple sclerosis management.
Patients with multiple sclerosis show increased oxidative stress markers and somatic telomere length shortening.
Dopaminergic dysfunction is associated with IL-1β-dependent mood alterations in experimental autoimmune encephalomyelitis.
Chromatin Landscape Defined by Repressive Histone Methylation during Oligodendrocyte Differentiation.
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders.
The Future of Research in Multiple Sclerosis.
Diagnostic value of 3D fluid attenuated inversion recovery sequence in multiple sclerosis.
Identification of candidate risk gene variations by whole-genome sequence analysis of four rat strains commonly used in inflammation research.
Cell fusion in the brain: two cells forward, one cell back.
What have we learned about the kallikrein-kinin and renin-angiotensin systems in neurological disorders?
Microglia and their CX3CR1 signaling are involved in hippocampal- but not olfactory bulb-related memory and neurogenesis.
Pharmacodynamic models for discrete data.
Time-Domain and Spectral-Domain Optical Coherence Tomography of Retinal Nerve Fiber Layer in MS Patients and Healthy Controls.
Acute disseminated encephalomyelitis following 2009 H1N1 influenza vaccine.
Effects of yoga interventions on fatigue: a meta-analysis.
Novel Agents for Relapsing Forms of Multiple Sclerosis.
A comparative analysis of Patient-Reported Expanded Disability Status Scale tools.
Neuromyelitis Optica Spectrum Disorder Associated with Cervical Spondylosis.
Sodium channels in astroglia and microglia.
Enrichment of Oligodendrocyte Progenitors from Differentiated Neural Precursors by Clonal Sphere Preparations.
The experimental autoimmune encephalomyelitis disease course is modulated by nicotine and other cigarette smoke components.
[Optic Neuritis.]
Morning glory syndrome associated with multiple sclerosis.
SEMA4D compromises blood-brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease.

Pages